Ludwika Piwowarczyk

Poznan, WP 60806, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Liposomal and Micellar-Based Nanoformulations of Fluorinated Curcumin Derivative and Naringenin-Comparative Studies.

Liposomal and Micellar-Based Nanoformulations of Fluorinated Curcumin Derivative and Naringenin-Comparative Studies.

Journal: Nanomaterials (Basel, Switzerland)

Published: June 24, 2026

Cannabidiol- and Celecoxib-Loaded Liposomes as a Strategy to Modulate Redox and Inflammatory Signaling in High-Grade Glioma: A Preliminary In Vivo Study.

Cannabidiol- and Celecoxib-Loaded Liposomes as a Strategy to Modulate Redox and Inflammatory Signaling in High-Grade Glioma: A Preliminary In Vivo Study.

Journal: International journal of molecular sciences

Published: June 02, 2026

Transferosomes Containing 20-Hydroxyecdysone for Psoriasis Treatment: Preparation, Characterization, and In Vitro and In Vivo Toxicity Assessment.

Transferosomes Containing 20-Hydroxyecdysone for Psoriasis Treatment: Preparation, Characterization, and In Vitro and In Vivo Toxicity Assessment.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: May 26, 2026

Cannabidiol in Gliomas: Therapeutic Potential and Nanocarrier Strategies, with an Emphasis on Vesicular Delivery Systems.

Cannabidiol in Gliomas: Therapeutic Potential and Nanocarrier Strategies, with an Emphasis on Vesicular Delivery Systems.

Journal: Molecular pharmaceutics

Published: November 25, 2025

The Anti-Glioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and 2,5-Dimethylcelecoxib.

The Anti-Glioblastoma Effects of Novel Liposomal Formulations Loaded with Cannabidiol, Celecoxib, and 2,5-Dimethylcelecoxib.

Journal: Pharmaceutics

Published: July 14, 2025

Antioxidants Acteoside and Orientin as Emerging Agents in Synergistic Cancer Therapy: A Focus on Innovative Applications.

Antioxidants Acteoside and Orientin as Emerging Agents in Synergistic Cancer Therapy: A Focus on Innovative Applications.

Journal: Antioxidants (Basel, Switzerland)

Published: June 10, 2025

Liposomal Co-Delivery of Acteoside, CBD, and Naringenin: A Synergistic Strategy Against Gliomas.

Liposomal Co-Delivery of Acteoside, CBD, and Naringenin: A Synergistic Strategy Against Gliomas.

Journal: Pharmaceutics

Published: May 31, 2025

Potential Use of Common Administration of Emulsion for Parenteral Nutrition and Vinpocetine: Compatibility Study and Prospect.

Potential Use of Common Administration of Emulsion for Parenteral Nutrition and Vinpocetine: Compatibility Study and Prospect.

Journal: Metabolites

Published: June 13, 2024

Tea-break with epigallocatechin gallate derivatives - Powerful polyphenols of great potential for medicine.

Tea-break with epigallocatechin gallate derivatives - Powerful polyphenols of great potential for medicine.

Journal: European journal of medicinal chemistry

Published: July 23, 2023

Natural Compounds in Liposomal Nanoformulations of Potential Clinical Application in Glioblastoma.

Natural Compounds in Liposomal Nanoformulations of Potential Clinical Application in Glioblastoma.

Journal: Cancers

Published: November 29, 2022

Role of curcumin in selected head and neck lesions. Limitations on the use of the Hep-2 cell line: A critical review.

Role of curcumin in selected head and neck lesions. Limitations on the use of the Hep-2 cell line: A critical review.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 05, 2022

Liposomal Nanoformulation as a Carrier for Curcumin and pEGCG-Study on Stability and Anticancer Potential.

Liposomal Nanoformulation as a Carrier for Curcumin and pEGCG-Study on Stability and Anticancer Potential.

Journal: Nanomaterials (Basel, Switzerland)

Published: February 25, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026